Analgesics in Spain

PROSPECTS

Popularity of reimbursable generic products to hamper sales growth in OTC analgesics

Competition from generics is limiting sales of OTC analgesics. In Spain the same active ingredient in analgesics can be bought as an OTC product or as a reimbursed product.

Healthier lifestyles to help topical analgesics/anaesthetic maintain its strong growth

Topical analgesics/anaesthetic will continue driving overall sales in analgesics. Spaniards are increasingly taking a more proactive role in terms of looking after their health.

The flu can still have a major influence on sales of analgesics

The flu can still be a major influencing factor on sales of analgesics. If there is a higher incidence of flu, then there will be greater consumption of analgesics, as analgesics are used to alleviate flu symptoms in Spain.

COMPETITIVE LANDSCAPE

Topical analgesics benefiting from novelties, such as Voltadol’s no-mess applicator

As a dynamic area of analgesics, topical analgesics continues to benefit from higher-than-average levels of innovation and novelty. Leading players understandably focus their efforts on categories that are recording the best performances, which is the case with topical analgesics.

GSK Consumer Healthcare continues to increase its share in analgesics

This is the type of innovation that helps GSK Consumer Healthcare consolidate its position as the leader in analgesics. Although it only has a relatively small minimal share in systemic analgesics, it is the clear leader in overall analgesics thanks to its very strong presence in topical analgesics.

Generics do not play a major role in OTC analgesics

There is no major presence of generics in OTC analgesics. Although the importance of generics keeps growing in the Spanish consumer health market, this is not the case in analgesics.

Files are delivered directly into your account within a few minutes of purchase.